Moreover, cell division analysis revealed that DOR prevents CML CD34+ from dividing and reduces the total number of CD34+ cells, with similar results observed in the IM + DOR treatment arm. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.